Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 357

Results For "SSI"

5625 News Found

Evonik invests in US based biopharma company ‘Allay Therapeutics’
News | December 13, 2022

Evonik invests in US based biopharma company ‘Allay Therapeutics’

Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks


US Federal Court dismisses cancer linkage associated with Zantac
News | December 13, 2022

US Federal Court dismisses cancer linkage associated with Zantac

The current ruling will assure the safety of the use of Ranitidine for Indian patients


Inclusion of Yoga in the treatment of breast cancer patients is highly beneficial
News | December 13, 2022

Inclusion of Yoga in the treatment of breast cancer patients is highly beneficial

The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama


Lupin launches generic version of Pennsaid in the US
News | December 12, 2022

Lupin launches generic version of Pennsaid in the US

Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)


PM addresses valedictory function of 9th World Ayurveda Congress
Policy | December 12, 2022

PM addresses valedictory function of 9th World Ayurveda Congress

Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine


National Health Ministers’ Conclave concludes in Varanasi
Policy | December 12, 2022

National Health Ministers’ Conclave concludes in Varanasi

They also released the Operational Guidelines for Wellness activities at AB-HWCs


Steps taken by Govt. to support diabetes patients
Policy | December 12, 2022

Steps taken by Govt. to support diabetes patients

As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years


Entod Pharmaceuticals to launch GLO division
News | December 12, 2022

Entod Pharmaceuticals to launch GLO division

This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma


Merck begins Tender Offer to acquire Imago BioSciences
News | December 12, 2022

Merck begins Tender Offer to acquire Imago BioSciences

As a result, Imago will become a subsidiary of Merck.


GSK announces new global headquarters in central London
News | December 12, 2022

GSK announces new global headquarters in central London

Company to open new headquarters in 2024